InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

Current share price for IDX : $1.740 0.01 (0.58%)+

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$650 Media Release FY18 Half Year Results 19 Jan 2018 8:34AM $2.280 $1.740 fallen by 23.68%
$650 Dividend/Distribution - IDX 19 Jan 2018 8:34AM $2.280 $1.740 fallen by 23.68%
$650 Half Yearly Report and Appendix 4D 19 Jan 2018 8:34AM $2.280 $1.740 fallen by 23.68%
$650 FY18 Half Year Results Release 18 Jan 2018 10:30AM $2.280 $1.740 fallen by 23.68%
$650 Change in substantial holding 17 Jan 2018 5:13PM $2.280 $1.740 fallen by 23.68%
$650 Material Upgrade to FY18 guidance 12 Jan 2018 10:27AM $2.280 $1.740 fallen by 23.68%
$650 Integral Diagnostics' Letter to Shareholders 22 Dec 2017 4:59PM $2.260 $1.740 fallen by 23.01%
$650 Capitol Bidder's Statement 22 Dec 2017 4:11PM $2.260 $1.740 fallen by 23.01%
$650 Release from Escrow 20 Dec 2017 12:19PM $2.250 $1.740 fallen by 22.67%
$650 Change of Director's Interest Notice - Ian Kadish 18 Dec 2017 6:45PM $2.240 $1.740 fallen by 22.32%
$650 Appendix 3B - Issue of Rights to Ian Kadish 18 Dec 2017 6:40PM $2.240 $1.740 fallen by 22.32%
$650 Letter to Shareholders regarding Capitol takeover offer 12 Dec 2017 2:10PM $2.190 $1.740 fallen by 20.55%
$650 Change in substantial holding 8 Dec 2017 4:44PM $2.230 $1.740 fallen by 21.97%
$650 Change of Director's Interest Notice - Raelene Murphy 4 Dec 2017 9:58AM $2.260 $1.740 fallen by 23.01%
$650 Appointment of CFO 30 Nov 2017 4:00PM $2.250 $1.740 fallen by 22.67%
$650 Initial response to hostile takeover offer from CAJ - date 29 Nov 2017 1:46PM $2.330 $1.740 fallen by 25.32%
$650 Initial response to hostile takeover offer from CAJ 29 Nov 2017 1:30PM $2.330 $1.740 fallen by 25.32%
$650 Becoming a substantial holder 29 Nov 2017 11:57AM $2.390 $1.740 fallen by 27.20%
$650 CAJ: Presentation - Capitol's Offer for Integral Diagnostics 29 Nov 2017 8:32AM $1.890 $1.740 fallen by 7.94%
$650 CAJ: Intention to make a t/o offer for Integral Diagnostics 29 Nov 2017 8:26AM $1.890 $1.740 fallen by 7.94%
$650 Change of Director's Interest Notice - Ian Kadish 28 Nov 2017 8:29AM $1.910 $1.740 fallen by 8.90%
$650 Change of Director's Interest Notice - Raelene Murphy 27 Nov 2017 5:01PM $1.910 $1.740 fallen by 8.90%
$650 Results of Annual General Meeting 22 Nov 2017 1:16PM $1.850 $1.740 fallen by 5.95%
$650 CEO AGM Presentation including Outlook 22 Nov 2017 10:05AM $1.800 $1.740 fallen by 3.33%
$650 Chairman & CEO Addresses to Shareholders 22 Nov 2017 10:01AM $1.800 $1.740 fallen by 3.33%

651 - 675 of 796 results

Page 27 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.